These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 34313238)

  • 21. Salvage Percutaneous Cryoablation for Locally Recurrent Renal-Cell Carcinoma After Primary Cryoablation.
    Okhunov Z; Chamberlin J; Moreira DM; George A; Babaian K; Shah P; Youssef R; Kaler KS; Lobko II; Kavoussi L; Landman J
    J Endourol; 2016 Jun; 30(6):632-7. PubMed ID: 27009377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiofrequency Ablation, Cryoablation, and Microwave Ablation for T1a Renal Cell Carcinoma: A Comparative Evaluation of Therapeutic and Renal Function Outcomes.
    Zhou W; Herwald SE; McCarthy C; Uppot RN; Arellano RS
    J Vasc Interv Radiol; 2019 Jul; 30(7):1035-1042. PubMed ID: 30956075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Laparoscopic renal cryoablation using ultrathin 17-gauge cryoprobes: mid-term oncological and functional results.
    Beemster PW; Barwari K; Mamoulakis C; Wijkstra H; de la Rosette JJ; Laguna MP
    BJU Int; 2011 Aug; 108(4):577-82. PubMed ID: 21044249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous Image-Guided Thermal Ablation for Multifocal Renal Cell Carcinoma: 10-Year Experience at a Single Center.
    Zhou W; Uppot RN; Feldman AS; Arellano RS
    AJR Am J Roentgenol; 2017 Oct; 209(4):733-739. PubMed ID: 28678572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transarterial embolization of T1b and T2a renal cell carcinoma prior to percutaneous cryoablation: a retrospective comparative study.
    Salei A; Raymond M; Savage C; Huang J; Caridi TM; Rais-Bahrami S; Gunn AJ
    Abdom Radiol (NY); 2023 Feb; 48(2):773-779. PubMed ID: 36454278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Percutaneous Cryoablation of Solitary, Sporadic Renal Cell Carcinoma: Outcome Analysis Based on Clear-Cell versus Papillary Subtypes.
    Haddad MM; Schmit GD; Kurup AN; Schmitz JJ; Boorjian SA; Geske J; Thompson RH; Callstrom MR; Atwell TD
    J Vasc Interv Radiol; 2018 Aug; 29(8):1122-1126. PubMed ID: 29887184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and Oncologic Outcomes of Percutaneous Cryoablation of Renal Cell Carcinoma Recurrences in the Ipsilateral Kidney Following Partial Nephrectomy.
    Rossi J; Cazzato RL; de Marini P; Auloge P; Autrusseau PA; Dalili D; Tricard T; Poussot B; Garnon J; Lang H; Gangi A
    Cardiovasc Intervent Radiol; 2022 May; 45(5):656-664. PubMed ID: 35274173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Percutaneous Microwave Ablation of Histologically Proven T1 Renal Cell Carcinoma.
    Aarts BM; Prevoo W; Meier MAJ; Bex A; Beets-Tan RGH; Klompenhouwer EG; Gómez FM
    Cardiovasc Intervent Radiol; 2020 Jul; 43(7):1025-1033. PubMed ID: 32052093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Percutaneous Cryoablation of Clinical T2 (> 7 cm) Renal Masses: Technical Considerations, Complications, and Short-Term Outcomes.
    Moynagh MR; Schmit GD; Thompson RH; Boorjian SA; Woodrum DA; Curry TB; Atwell TD
    J Vasc Interv Radiol; 2015 Jun; 26(6):800-6. PubMed ID: 25840835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor location does not impact oncologic outcomes for percutaneous microwave ablation of clinical T1a renal cell carcinoma.
    Maciolek KA; Abel EJ; Posielski NM; Hinshaw JL; Lubner MG; Lee FT; Ziemlewicz TJ; Wells SA
    Eur Radiol; 2019 Nov; 29(11):6319-6329. PubMed ID: 31016448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
    Andrews JR; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Eur Urol; 2019 Aug; 76(2):244-251. PubMed ID: 31060824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Tumor Complexity and Technique on Efficacy and Complications after Percutaneous Microwave Ablation of Stage T1a Renal Cell Carcinoma: A Single-Center, Retrospective Study.
    Klapperich ME; Abel EJ; Ziemlewicz TJ; Best S; Lubner MG; Nakada SY; Hinshaw JL; Brace CL; Lee FT; Wells SA
    Radiology; 2017 Jul; 284(1):272-280. PubMed ID: 28076721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Image-guided percutaneous cryoablation of T1b renal cell carcinomas in patients with comorbidities.
    Shimizu K; Enoki K; Kameoka Y; Motohashi K; Yanagisawa T; Miki J; Baba A; Sekiguchi H; Sadaoka S
    Jpn J Radiol; 2021 Dec; 39(12):1213-1222. PubMed ID: 34228240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Percutaneous thermoablation of small renal masses (T1a) in surgical candidate patients: oncologic outcomes.
    Zangiacomo RN; Martins GLP; Viana PCC; Horvat N; Arap MA; Nahas WC; Srougi M; Cerri GG; Menezes MR
    Eur Radiol; 2021 Jul; 31(7):5370-5378. PubMed ID: 33392662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Percutaneous Microwave Ablation of Category T1a Renal Cell Carcinoma: Intermediate Results on Safety, Technical Feasibility, and Clinical Outcomes of 119 Tumors.
    Guo J; Arellano RS
    AJR Am J Roentgenol; 2021 Jan; 216(1):117-124. PubMed ID: 32603227
    [No Abstract]   [Full Text] [Related]  

  • 36. [Percutaneous CT-guided radiofrequency ablation for small renal masses : A retrospective, single center data analysis].
    Heißler O; Seklehner S; Fellner H; Engelhardt PF; Chemelli A; Riedl C
    Urologe A; 2018 Jul; 57(7):828-835. PubMed ID: 29797025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thermal Ablation of T1c Renal Cell Carcinoma: A Comparative Assessment of Technical Performance, Procedural Outcome, and Safety of Microwave Ablation, Radiofrequency Ablation, and Cryoablation.
    Zhou W; Arellano RS
    J Vasc Interv Radiol; 2018 Jul; 29(7):943-951. PubMed ID: 29628298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Percutaneous image-guided cryoablation with temporary balloon occlusion of the renal artery for the treatment of central renal tumors.
    Autrusseau PA; Boatta E; Cazzato RL; Auloge P; Mayer T; Weiss J; Koch G; Caudrelier J; De Marini P; Gangi A; Garnon J
    Diagn Interv Imaging; 2022 Nov; 103(11):510-515. PubMed ID: 35934617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Percutaneous computed tomography-guided cryoablation for renal tumor: Experience in 30 cases.
    Lai WJ; Chung HJ; Chen CK; Shen SH; Chou HP; Chiou YY; Wang JH; Chang CY
    J Chin Med Assoc; 2015 May; 78(5):308-15. PubMed ID: 25700943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Percutaneous cryoablation of renal masses: Washington University experience of treating 129 tumours.
    Kim EH; Tanagho YS; Bhayani SB; Saad NE; Benway BM; Figenshau RS
    BJU Int; 2013 May; 111(6):872-9. PubMed ID: 23145500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.